{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:46:46Z","timestamp":1793321206160,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Early-stage colorectal cancer (CRC) is often treated endoscopically, but additional surgical resection may be considered depending on pathological findings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 73-year-old man was found to have early-stage sigmoid colon cancer by colonoscopy during a medical examination, and endoscopic mucosal resection (EMR) was performed. The lesion was a 7-mm-sized sessile polyp, and the pathological diagnosis was well-differentiated tubular adenocarcinoma, pT1 (submucosal invasion of 400\u00a0\u03bcm), with no lymphovascular invasion, low budding grade, and negative horizontal and vertical margins. Therefore, the patient was observed without postoperative treatment. One year later, a computed tomography (CT) scan showed multiple liver metastases. After five courses of preoperative chemotherapy with folinic acid, 5-fluorouracil and oxaliplatin (FOLFOX) and panitumumab, liver metastases were reduced. The patient underwent extended right hepatic lobectomy. The pathological finding was well-to-moderately differentiated tubular adenocarcinoma, and immunohistochemistry findings were consistent with liver metastases from sigmoid colon cancer. Postoperatively, the patient received five courses adjuvant chemotherapy with FOLFOX. Although the patient had been recurrence-free for 5\u00a0years after liver resection, a CT scan revealed a nodular lesion in the sigmoid mesentery. Positron emission tomography (PET) showed abnormal accumulation in the same lesion. Therefore, the mesenteric nodules diagnosed as lymph metastasis and recurrence of sigmoid colon cancer and performed laparoscopic sigmoid colon resection with lymph node dissection. The pathological findings showed that the recurrent lesion in the mesentery formed a nodular infiltrate with venous, lymphatic, and neural invasion, but lymph node structures were not found, and it was assumed to be metastasis or recurrence due to lymphovascular invasion. The pathologic specimen of the sigmoid colon had no neoplastic lesions, which are considered to be a local recurrence on the mucosal surface. After sigmoid colectomy, adjuvant chemotherapy with CapeOX was conducted, and the patient has been recurrence-free for 13\u00a0months at present.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Even early-stage CRCs that have no pathological indications for additional resection have risks of metastases and recurrences, and we may need to consider that the criteria for additional resection should not be limited to pathological findings alone.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40792-023-01731-7","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T04:01:31Z","timestamp":1693454491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early-stage sigmoid colon cancer resection followed by liver metastasis recurrence 1\u00a0year later and mesenteric recurrence more than 5\u00a0years later: a case report"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1746-5554","authenticated-orcid":false,"given":"Yumeto","family":"Mikuni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuki","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Emoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigenori","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahashi","family":"Norihiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Taketomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"issue":"1","key":"1731_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-019-01485-z","volume":"25","author":"Y Hashiguchi","year":"2020","unstructured":"Hashiguchi Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25(1):1\u201342.","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"1731_CR2","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/j.1440-1746.2011.07041.x","volume":"27","author":"K Nakadoi","year":"2012","unstructured":"Nakadoi K, et al. Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection. J Gastroenterol Hepatol. 2012;27(6):1057\u201362.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"1731_CR3","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1055\/s-0031-1291665","volume":"44","author":"JH Suh","year":"2012","unstructured":"Suh JH, et al. Predictors for lymph node metastasis in T1 colorectal cancer. Endoscopy. 2012;44(6):590\u20135.","journal-title":"Endoscopy"},{"issue":"2","key":"1731_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10147-015-0801-z","volume":"20","author":"T Watanabe","year":"2015","unstructured":"Watanabe T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 2015;20(2):207\u201339.","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"1731_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s00535-004-1339-4","volume":"39","author":"K Kitajima","year":"2004","unstructured":"Kitajima K, et al. Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol. 2004;39(6):534\u201343.","journal-title":"J Gastroenterol"},{"issue":"4","key":"1731_CR6","first-page":"783","volume":"7","author":"S Tanaka","year":"2000","unstructured":"Tanaka S, et al. Conditions of curability after endoscopic resection for colorectal carcinoma with submucosally massive invasion. Oncol Rep. 2000;7(4):783\u20138.","journal-title":"Oncol Rep"},{"issue":"2","key":"1731_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1053\/j.gastro.2004.04.022","volume":"127","author":"H Ueno","year":"2004","unstructured":"Ueno H, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 2004;127(2):385\u201394.","journal-title":"Gastroenterology"},{"issue":"3","key":"1731_CR8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s005350050270","volume":"34","author":"K Okano","year":"1999","unstructured":"Okano K, Shimoda T, Matsumura Y. Clinicopathologic and immunohistochemical study of early colorectal cancer with liver metastases. J Gastroenterol. 1999;34(3):334\u201340.","journal-title":"J Gastroenterol"},{"issue":"65","key":"1731_CR9","first-page":"1421","volume":"52","author":"H Mitomi","year":"2005","unstructured":"Mitomi H, et al. Venous invasion and down-regulation of p21(WAF1\/CIP1) are associated with metastasis in colorectal carcinomas. Hepatogastroenterology. 2005;52(65):1421\u20136.","journal-title":"Hepatogastroenterology"},{"issue":"4","key":"1731_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10147-014-0778-z","volume":"20","author":"Y Okamoto","year":"2015","unstructured":"Okamoto Y, et al. Effect of skip lymphovascular invasion on hepatic metastasis in colorectal carcinomas. Int J Clin Oncol. 2015;20(4):761\u20136.","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"1731_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1053\/j.gastro.2012.12.003","volume":"144","author":"H Ikematsu","year":"2013","unstructured":"Ikematsu H, et al. Long-term outcomes after resection for submucosal invasive colorectal cancers. Gastroenterology. 2013;144(3):551\u20139 (quiz e14).","journal-title":"Gastroenterology"},{"issue":"9","key":"1731_CR12","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrc3793","volume":"14","author":"MS Sosa","year":"2014","unstructured":"Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14(9):611\u201322.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"1731_CR13","volume":"2015","author":"BD Nicholson","year":"2015","unstructured":"Nicholson BD, et al. Blood CEA levels for detecting recurrent colorectal cancer. Cochrane Database Syst Rev. 2015;2015(12): Cd011134.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1731_CR14","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/cas.13972","volume":"110","author":"H Osumi","year":"2019","unstructured":"Osumi H, et al. Clinical utility of circulating tumor DNA for colorectal cancer. Cancer Sci. 2019;110(4):1148\u201355.","journal-title":"Cancer Sci"},{"issue":"346","key":"1731_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf6219","volume":"8","author":"J Tie","year":"2016","unstructured":"Tie J, et al. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci Transl Med. 2016;8(346): 346ra92.","journal-title":"Sci Transl Med"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-023-01731-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40792-023-01731-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-023-01731-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T12:21:50Z","timestamp":1700482910000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-023-01731-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1731"],"URL":"https:\/\/doi.org\/10.1186\/s40792-023-01731-7","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"assertion":[{"value":"5 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from the patient for publication of this report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All of authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}